|
BREAKING NEWS & VIEWS
Access Intelligence Gets Health Coverage – Acquires Contexo Contexo is both a business information and a services company. In addition to medical billing and case management products in the healthcare market, it also runs Dorland Health, a 50-year-old publisher of medical content such as Case in Point magazine. In a statement, AI CEO Don Pazour says, “We find the medical coding and case management products the hallmark of the highest-quality found in the marketplace. We are excited to employ our best-of-breed content and sales and marketing solutions to build market share and mind share within the community.” Access Intelligence, itself a portfolio company of Veronis Suhler Stevenson, publishes multiple titles across a range of verticals, including chemical (Chemical Engineering and Chemical Week), defense (Defense Daily), media and PR (min and PR News), energy and cable (CableFAX). This purchase extends AI into the managed health care field and will be organized as the Contexo Media Division to be overseen by AI Business Information Group president Heather Farley. If you have breaking news to share please contact Steve Smith at ssmith@accessintel.com |
Sr. Marketing Manager, Confidential
Online Media Sales Executive, eBusiness, Reed Exhibitions Web Programmer, Werner Publishing Corp Media Jobs | Job Alerts | Post Your Resume White Papers
Get even smarter -- download a white paper today.
Featured White Papers:All Content is Now Evergreen By nstein Making the Move: Tips on How to Create Digitally-Optimized MagazinesBy Nxtbook Media Design ... more Whitepapers min Contests
Events Calendar
February 16, 2010 min Webinar: How to Monetize Your Video Streams Now Learn More February 25, 2010 Managing and Monetizing the Magazine Content Eco-System Learn More February 28-3, 2010 4A's Transformation 2010 Learn More |
| Copyright © 2010 Access Intelligence, LLC. All rights reserved. Reproduction in whole or in part in any form or medium without express written permission of Access Intelligence, LLC is prohibited. For more details please see Terms and Conditions. |